Coming Soon: the Power List
By Rob Coker
April 11, 2025
The 2025 Power List will be available soon!
2 min read
Small Molecules
Combatting the Side Effects of Treatments for Parkinson’s
April 7, 2025
Celon Pharma CEO hopes their new compound could be a potential breakthrough for Parkinson’s patients.
4 min read
Antibiotics: Going With the Flow
By Rob Coker
April 2, 2025
How fluid flow through the body can affect the ways in which antibiotics work.
2 min read
The Future of the NIH
By Hernan Bazan
March 27, 2025
Thoughts on the US National Institutes of Health and its role in funding research for non-opioid therapeutics.
2 min read
Calling Out Misleading Information
By Rob Coker
March 24, 2025
FDA letter sent to Edenbridge Pharmaceuticals demonstrates the challenges of getting pharma advertising right.
2 min read
The Myths and Reality of Hot Melt Extrusion
By Hibreniguss Terefe, Shahab Kashani Rahimi
March 20, 2025
How hot melt extrusion can enhance drug solubility and bioavailability, offering advantages over spray drying for oral dosage form development.
6 min read
GSK’s Flovent Strategy Under Federal Scrutiny?
By Rob Coker
March 19, 2025
US Senator Elizabeth Warren calls for a federal investigation into GSK and its discontinuation of Flovent HFA.
2 min read
Co-Crystals Shine in Innovation Awards
March 14, 2025
Celebrating the winner of our annual Innovation Awards: a service for co-crystal prediction
1 min read
Regulation & Standards
Regulation & Standards
Business & Trends
Drug Discovery
Research News
Small Molecules
AMF’s 2026 AMR Strategy, Revealed
By Rob Coker
February 24, 2025
The Access to Medicine Foundation has developed the 2026 AMR Benchmark to recognize and promote urgency in the ongoing AMR challenge.
3 min read
Three Trends to Watch in Oral Solid Dosages
By Jennifer Gattari
February 19, 2025
Oral solid dosages remain the world’s most popular dosage form, but their increasing complexity brings challenges.
4 min read
